{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:48:43Z","timestamp":1789051723897,"version":"build-2803163510"},"reference-count":51,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Military Young Sci-Tech Talents Project"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Accurate assessment of the inflammatory status in thyroid eye disease (TED) is crucial for diagnosis and treatment; however, this assessment remains challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To study whether thyrotrophin receptor antibody (TRAb) can be utilized as a quantitative and objective indicator of the inflammatory status in patients with TED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We gathered and analyzed TRAb and clinical characteristics from 226 consecutive TED patients. Additionally, we examined 27 inflammatory cytokines in the orbital adipose tissue of 41 patients and assessed the alterations in TRAb following IV methylprednisolone (IVMP) therapy in 40 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 226 TED patients included 116 females and 110 males, with a mean age of 46.4 \u00b1 12.2 years. The correlation between TRAb and clinical activity score (CAS) was the most pronounced (r = 0.427; P &amp;lt; .001). TRAb was identified as the most influential factor for CAS. Subsequent investigation into the relationship between TRAb and pathological inflammation revealed that TRAb exhibited a significant positive correlation with 7 proinflammatory cytokines [Interleukin (IL)-8, chemokine (C-C motif) ligand 3 (CCL-3), serpin E1, platelet-derived growth factor (PDGF)-AB, IL-12p70, IL-21, and PDGF-BB] and a significant negative correlation with 1 anti-inflammatory cytokine [bone morphogenetic protein 7 (BMP-7)]. IL-8, CCL-3, serpin E1, PDGF-AB, and IL-1\u03b2 were significantly upregulated in the orbital adipose tissue of TRAb-positive patients compared to TRAb-negative patients. In contrast, BMP-7 demonstrated an opposite trend. Additionally, TRAb and CAS significantly decreased following IVMP therapy, with a significant correlation between the extent of reduction in TRAb and CAS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TRAb significantly correlated with both CAS (clinical inflammation indicator) and inflammatory cytokines (pathological inflammation marker). Consequently, we propose, for the first time, that TRAb may serve as an objective and quantitative biomarker for assessing inflammation in TED.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf273","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T07:36:45Z","timestamp":1746689805000},"page":"e260-e269","source":"Crossref","is-referenced-by-count":6,"title":["Thyrotrophin Receptor Antibody: Objective and Quantitative Inflammatory Indicator in Patients With Thyroid Eye Disease"],"prefix":"10.1210","volume":"111","author":[{"given":"Gaojing","family":"Jing","sequence":"first","affiliation":[{"name":"Senior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital , Beijing 100080 ,","place":["China"]},{"name":"Department of Endocrinology, The First Hospital of Lanzhou University, The First Clinical Medical College, Lanzhou University , Lanzhou 730000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Tang","sequence":"additional","affiliation":[{"name":"Senior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital , Beijing 100080 ,","place":["China"]},{"name":"School of Clinical Medicine, Shandong Second Medical University , Weifang 261000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[{"name":"Senior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital , Beijing 100080 ,","place":["China"]},{"name":"School of Clinical Medicine, Shandong Second Medical University , Weifang 261000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Li","sequence":"additional","affiliation":[{"name":"Senior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital , Beijing 100080 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[{"name":"Senior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital , Beijing 100080 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Kang","sequence":"additional","affiliation":[{"name":"Senior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital , Beijing 100080 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Yang","sequence":"additional","affiliation":[{"name":"Senior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital , Beijing 100080 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, 3rd Medical Center of Chinese PLA General Hospital , Beijing 100080 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengshu","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, 2nd Medical Center of Chinese PLA General Hospital , Beijing 100080 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulei","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Hospital of Lanzhou University, The First Clinical Medical College, Lanzhou University , Lanzhou 730000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbo","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Hospital of Lanzhou University, The First Clinical Medical College, Lanzhou University , Lanzhou 730000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4567-9366","authenticated-orcid":false,"given":"Xinji","family":"Yang","sequence":"additional","affiliation":[{"name":"Senior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital , Beijing 100080 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7097-2150","authenticated-orcid":false,"given":"Wei","family":"Wu","sequence":"additional","affiliation":[{"name":"Senior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital , Beijing 100080 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"issue":"1","key":"2025121807430042500_dgaf273-B1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s42000-023-00498-8","article-title":"Understanding the clinical and molecular basis of thyroid orbitopathy: a review of recent evidence","volume":"23","author":"Nivean","year":"2024","journal-title":"Hormones"},{"issue":"3","key":"2025121807430042500_dgaf273-B2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.survophthal.2021.08.010","article-title":"Thinking inside the box: current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease","volume":"67","author":"Gupta","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"2025121807430042500_dgaf273-B3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach","volume":"73","author":"Mourits","year":"1989","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2025121807430042500_dgaf273-B4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol"},{"issue":"4","key":"2025121807430042500_dgaf273-B5","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2025121807430042500_dgaf273-B6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1089\/thy.2022.0251","article-title":"Management of thyroid eye disease: a consensus statement by the American thyroid association and the European thyroid association","volume":"32","author":"Burch","year":"2022","journal-title":"Thyroid"},{"key":"2025121807430042500_dgaf273-B7","doi-asserted-by":"crossref","first-page":"1292519","DOI":"10.3389\/fendo.2023.1292519","article-title":"Predictive markers for anti-inflammatory treatment response in thyroid eye disease","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2025121807430042500_dgaf273-B8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13244-024-01693-w","article-title":"Dixon MRI-based quantitative parameters of extraocular muscles, intraorbital fat, and lacrimal glands for staging thyroid-associated ophthalmopathy","volume":"15","author":"Pu","year":"2024","journal-title":"Insights Imaging"},{"key":"2025121807430042500_dgaf273-B9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajo.2023.03.027","article-title":"Inter-observer variability of clinical activity score: assessments in patients with thyroid eye disease","volume":"252","author":"Perros","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2025121807430042500_dgaf273-B10","doi-asserted-by":"crossref","first-page":"101620","DOI":"10.1016\/j.beem.2022.101620","article-title":"Pathophysiology of thyroid-associated orbitopathy","volume":"37","author":"Lee","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2025121807430042500_dgaf273-B11","doi-asserted-by":"crossref","first-page":"654473","DOI":"10.3389\/fendo.2021.654473","article-title":"Cytokines as targets of novel therapies for Graves\u2019 ophthalmopathy","volume":"12","author":"Fallahi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2025121807430042500_dgaf273-B12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/EJE-22-0247","article-title":"Novel inflammatory biomarkers in thyroid eye disease","volume":"187","author":"Ueland","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025121807430042500_dgaf273-B13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ymgme.2003.09.001","article-title":"Thyroid-stimulating hormone receptor and its role in Graves\u2019 disease","volume":"80","author":"Chistiakov","year":"2003","journal-title":"Mol Genet Metab"},{"issue":"3","key":"2025121807430042500_dgaf273-B14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejim.2011.02.006","article-title":"The role of TSH receptor antibodies in the management of Graves\u2019 disease","volume":"22","author":"Matthews","year":"2011","journal-title":"Eur J Intern Med"},{"issue":"4S","key":"2025121807430042500_dgaf273-B15","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IOP.0000000000001052","article-title":"Thyrotropin receptor antibodies\u2014an overview","volume":"34","author":"Kotwal","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"2025121807430042500_dgaf273-B16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.beem.2011.10.003","article-title":"Immunopathogenesis of Graves\u2019 ophthalmopathy: the role of the TSH receptor","volume":"26","author":"Iyer","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"2025121807430042500_dgaf273-B17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1677\/jme.0.0300369","article-title":"Adipose thyrotrophin receptor expression is elevated in Graves\u2019 and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo","volume":"30","author":"Starkey","year":"2003","journal-title":"J Mol Endocrinol"},{"key":"2025121807430042500_dgaf273-B18","doi-asserted-by":"crossref","first-page":"629925","DOI":"10.3389\/fendo.2020.629925","article-title":"Stimulatory thyrotropin receptor antibodies are a biomarker for Graves\u2019 orbitopathy","volume":"11","author":"George","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025121807430042500_dgaf273-B19","doi-asserted-by":"crossref","first-page":"1340415","DOI":"10.3389\/fendo.2024.1340415","article-title":"Thyroid stimulating immunoglobulin concentration is associated with disease activity and predicts response to treatment with intravenous methylprednisolone in patients with Graves\u2019 orbitopathy","volume":"15","author":"H\u00f6tte","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2025121807430042500_dgaf273-B20","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0002-9394(14)72787-4","article-title":"Diagnostic criteria for Graves\u2019 ophthalmopathy","volume":"119","author":"Bartley","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"2025121807430042500_dgaf273-B21","doi-asserted-by":"crossref","unstructured":"Jing G, Tang J, Li Y, et al \u00a0Supplemental Materials for \u201cThyrotrophin receptor antibody: objective and quantitative inflammatory indicator in patients with thyroid eye disease\u201d. Mendeley Data 2025. Deposited 4 April 2025. V1, doi:10.17632\/582fht9bdz.","DOI":"10.1210\/clinem\/dgaf273"},{"issue":"5","key":"2025121807430042500_dgaf273-B22","doi-asserted-by":"crossref","first-page":"e0176064","DOI":"10.1371\/journal.pone.0176064","article-title":"Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"2025121807430042500_dgaf273-B23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.eye.6701925","article-title":"Exophthalmos of patients with Graves\u2019 disease in Chinese of Taiwan","volume":"20","author":"Tsai","year":"2006","journal-title":"Eye"},{"issue":"2","key":"2025121807430042500_dgaf273-B24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0889-8529(18)30485-7","article-title":"Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy","volume":"16","author":"Bahn","year":"1987","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"2025121807430042500_dgaf273-B25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9394(77)90140-4","article-title":"Modification of the classification of the eye changes of Graves\u2019 disease","volume":"83","author":"Werner","year":"1977","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2025121807430042500_dgaf273-B26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40618-021-01652-y","article-title":"Clinical value of functional thyrotropin receptor antibodies in Serbian patients with Graves\u2019 orbitopathy","volume":"45","author":"Sari\u0107 Matutinovi\u0107","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2025121807430042500_dgaf273-B27","first-page":"473","article-title":"Studies on the occurrence of ophthalmopathy in Graves\u2019 disease","volume":"120","author":"Marcocci","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"2","key":"2025121807430042500_dgaf273-B28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/bjo-2022-322442","article-title":"Presentation of Graves\u2019 orbitopathy within European group on Graves\u2019 orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)","volume":"108","author":"Schuh","year":"2024","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"2025121807430042500_dgaf273-B29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2025121807430042500_dgaf273-B30","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1210\/jc.2006-1402","article-title":"Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype","volume":"91","author":"Manji","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025121807430042500_dgaf273-B31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.1993.tb00516.x","article-title":"Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic","volume":"38","author":"Perros","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025121807430042500_dgaf273-B32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajo.2024.03.005","article-title":"Thyroid eye disease: pilot study comparison between patients in United States-based and India-based practices","volume":"264","author":"Ramesh","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"2025121807430042500_dgaf273-B33","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s40618-023-02085-5","article-title":"The phenotype of Graves\u2019 orbitopathy is associated with thyrotropin receptor antibody levels","volume":"46","author":"Sari\u0107 Matutinovi\u0107","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"2025121807430042500_dgaf273-B34","doi-asserted-by":"crossref","first-page":"678194","DOI":"10.1155\/2015\/678194","article-title":"Thyroid stimulating but not blocking autoantibodies are highly prevalent in severe and active thyroid-associated orbitopathy: a prospective study","volume":"2015","author":"Kampmann","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"7","key":"2025121807430042500_dgaf273-B35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s40618-015-0254-2","article-title":"Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy","volume":"38","author":"Ponto","year":"2015","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2025121807430042500_dgaf273-B36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40618-020-01353-y","article-title":"Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves\u2019 orbitopathy","volume":"44","author":"Nicol\u00ec","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2025121807430042500_dgaf273-B37","first-page":"1597","article-title":"Blocking the thyrotropin receptor with K1-70 in a patient with follicular thyroid cancer, Graves\u2019 disease, and Graves\u2019 ophthalmopathy","volume":"31","author":"Ryder","year":"2021","journal-title":"Thyroid"},{"issue":"1","key":"2025121807430042500_dgaf273-B38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0016-5085(92)91137-S","article-title":"Interleukin 8, neutrophils, and acute inflammation","volume":"103","author":"Shanahan","year":"1992","journal-title":"Gastroenterology"},{"issue":"6","key":"2025121807430042500_dgaf273-B39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/09273948.2011.618902","article-title":"Roles of IL-8 in ocular inflammations: a review","volume":"19","author":"Ghasemi","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"2025121807430042500_dgaf273-B40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1\u03b2 secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"2025121807430042500_dgaf273-B41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","article-title":"TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves\u2019 ophthalmopathy patients","volume":"58","author":"Wakelkamp","year":"2003","journal-title":"Clin Endocrinol"},{"issue":"6","key":"2025121807430042500_dgaf273-B42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1","volume":"13","author":"Menten","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8","key":"2025121807430042500_dgaf273-B43","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3390\/cells9081799","article-title":"MIP-1\u03b1 expression induced by co-stimulation of human monocytic cells with palmitate and TNF-\u03b1 involves the TLR4-IRF3 pathway and is amplified by oxidative stress","volume":"9","author":"Sindhu","year":"2020","journal-title":"Cells"},{"issue":"2","key":"2025121807430042500_dgaf273-B44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2265.2003.01824.x","article-title":"Detection and localization of chemokine gene expression in autoimmune thyroid disease","volume":"59","author":"Kemp","year":"2003","journal-title":"Clin Endocrinol"},{"key":"2025121807430042500_dgaf273-B45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2018.11.004","article-title":"Molecular biomarkers of Graves\u2019 ophthalmopathy","volume":"106","author":"Longo","year":"2019","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"2025121807430042500_dgaf273-B46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/thy.2011.0248","article-title":"Graves\u2019 orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines","volume":"22","author":"Ujhelyi","year":"2012","journal-title":"Thyroid"},{"issue":"1","key":"2025121807430042500_dgaf273-B47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1871530319666190618142215","article-title":"Proteomics screening of differentially expressed cytokines in tears of patients with Graves\u2019 ophthalmopathy","volume":"20","author":"Song","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"6","key":"2025121807430042500_dgaf273-B48","doi-asserted-by":"crossref","first-page":"E944","DOI":"10.1210\/jc.2012-1020","article-title":"PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves\u2019 ophthalmopathy patients","volume":"97","author":"van Steensel","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025121807430042500_dgaf273-B49","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1167\/iovs.09-4338","article-title":"Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves\u2019 ophthalmopathy","volume":"51","author":"van Steensel","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2025121807430042500_dgaf273-B50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.63.6.7","article-title":"Potential therapeutic role of bone morphogenic protein 7 (BMP7) in the pathogenesis of Graves\u2019 orbitopathy","volume":"63","author":"Kim","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2025121807430042500_dgaf273-B51","doi-asserted-by":"crossref","first-page":"554","DOI":"10.5603\/EP.2016.0073","article-title":"The efficacy of immunosuppressive treatment of Graves\u2019 orbitopathy is not affected by previous anti-thyroid drugs or by radioiodine therapy of Graves\u2019 disease","volume":"67","author":"Jagie\u0142\u0142o-Korzeniowska","year":"2016","journal-title":"Endokrynol Pol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf273\/63138931\/dgaf273.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/1\/e260\/63138931\/dgaf273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/1\/e260\/63138931\/dgaf273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:44:20Z","timestamp":1766061860000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/1\/e260\/8128067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,5,9]]},"published-print":{"date-parts":[[2025,12,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf273","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,5,9]]}}}